Absence of Effect of Somatostatin Analogue (SMS 201-995) in Diarrhea Associated with Inflammatory Bowel Disease
The octapeptide long acting somatostatin analogue, SMS 201-995 promotes intestinal fluid and electrolyte absorption and inhibits anion secretion. It is more potent than native somatostatin and does not exhibit tachyphylaxsis. SMS 201-995 was used to treat two patients with severe diarrhea associated...
Saved in:
Main Authors: | Richard N. Fedorak, Richard W. Sherbaniuk |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1989-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1989/525713 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Somatostatin in inflammatory bowel disease
by: J. D. Van Bergeijk, et al.
Published: (1997-01-01) -
Association of Pathology Markers with Somatostatin Analogue Responsiveness in Acromegaly
by: George Kontogeorgos, et al.
Published: (2022-01-01) -
Efficacy and predictors of response to somatostatin analogues in patients with ectopic ACTH syndrome
by: Olga O. Golounina, et al.
Published: (2024-12-01) -
Exercise and Inflammatory Bowel Disease
by: Neeraj Narula, et al.
Published: (2008-01-01) -
Erratum to “Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study”
by: Ming Shen, et al.
Published: (2019-01-01)